Larotinib
Larotinib is a potent, orally bioavailable broad-spectrum tyrosine kinase inhibitor, exhibiting high potency against EGFR with an IC50 of 0.6 nM. It is utilized in cancer research for investigating oncogenic signaling pathways in both cellular and animal models of EGFR-driven malignancies.
Product Specifications
CAS Number
1438072-11-7
Product Name Alternative
Tyrosine Kinases, TyrosineKinases, BTK, IRAK, EGFR
Field of Research
Cardiovascular Research, Immunology & Inflammation, Signal Transduction
Purity
98.45% (May vary between batches)
Solubility
DMSO:60 mg/mL (122.71 mM)
Smiles
N (C=1C2=C (C=C (OC) C (OCCCN3C[C@@]4 ([C@] (C3) (OCCO4) [H]) [H]) =C2) N=CN1) C5=CC (Cl) =C (F) C=C5
Molecular Formula
C24H26ClFN4O4
Molecular Weight
488.94
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LH13392V 100 µg
Collagen VI (COL6A2) (NM_058174) Human Over-expression Lysate
Sign In for Pricing
View Details 
RC207723L3V 200 µL
KCTD10 (NM_031954) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
K1337105 3x 1.0 µg
MRPS25 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
bs-7747R-BF750 100 µL
DCTN6 Polyclonal Antibody, AbBy Fluor™ 750 Conjugated
Sign In for Pricing
View Details